Products Details
Indication:
• Prophylaxis and treatment of infection in burn wounds
• As an adjunct to short-term treatment of infection in :
• Leg ulcers
• Pressure sores
• As an adjunct to prophylaxis of infection in:
• Skin graft donor sites
• Extensive abrasions
• Conservative management of finger-tip injuries
Dosage & Administration:
Direction for use
Burns: The burn wound should be cleaned and Silverzine applied over-all
the affected areas to a depth of 3-5 mm. This application is best achieved
with a sterile gloved hand and/or sterile spatula. Where necessary, the cream
should be re-applied to any are from which it has been removed by patient
activity. In burn, Silverzine should be re-applied at least every 24 hours, or more frequently if the volume of exudates is large.
Hand burns: Silverzine can be applied to the burn and the whole hand
enclosed in as clean plastic bag or glove which is then closed at the wrist.
The patient should be encouraged to move the hand and fingers. The
dressing should be changed when an excessive amount of exudates has
accumulated in the bag.
Leg ulcer/pressure sores: The cavity of ulcer should be filled with
Silverzine to a depth of at least 3-5 mm. As Silverzine can cause
maceration of normal skin on prolonged contact, care should be taker to
prevent spread onto non-ulcerated areas. Application of Silverzine should
be followed by an absorbent pad or gauze dressing, with further application
of pressure bandaging as appropriate for the ulcer. The dressings should
normally be changed daily but for wounds which are less exudative, less
frequent changes (every 48 hours) may be acceptable. Cleansings and
debriding should be performed before application of Silverzine. Silverzine
in not recommended for use in leg or pressure ulcer that are very exudative.
Finger-tip injuries: Haemostasis of the injury should be achieved prior to
the application of a 3-5 mm layer of Silverzine. A conventional finger
dressing may be used. Alternatively the fingers of a plastic or surgical glove
can be used and fixed in place with waterproof adhesive tape. Dressings
should be changed every 2-3 days.
Contraindication:
It is contraindicated in-patients who are hypersensitive to it or any of the
other ingredients in the preparation. It should not be used on pregnant
women approaching or at term, on premature infants, or on newborn infants
during the first 2 months of life.
Side Effect:
Several cases of transient leukopenia have been reported in-patients
receiving Silver Sulfadiazine therapy. Other infrequently occurring events
include skin necrosis, erythema multiform, skin discoloration, burning
sensation, rashes, and interstitial nephritis.
Precautions:
If hepatic and renal functions become impaired and elimination of drug
decreases, accumulation may occur and discontinuation of Silverzine
should be weighed against the therapeutic benefit being achieved. In
considering the use of topical proteolytic enzymes in conjunction with
Silverzine, the possibility should be noted that silver may inactivate such
enzyme. In the treatment of burn wounds involving extensive areas of the
body, the serum sulfa concentration. Renal function should be careful
mentioned. The urine should be checked for sulfa crystals.
Use in Pregnancy and Lactation:
Teratogenic Effects: Pregnancy Category B. This drug should be used
during pregnancy only if clearly justified, especially in pregnant women
approaching or at term.
Nursing Mothers: It is not known whether Silver Sulfadiazine is excreted in
human
milk. A decision should be made, whether to discontinue nursing or to
discontinue the
drug, taking into account the importance of the drug to the mother.